Get the Stockscreener App
6.76
5.30%
0.34
After Hours:
5.50
-1.26
-18.64%
Pepgen Inc stock is traded at $6.76, with a volume of 1.10M.
It is up +5.30% in the last 24 hours and up +37.68% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$6.42
Open:
$6.23
24h Volume:
1.10M
Relative Volume:
1.67
Market Cap:
$464.74M
Revenue:
-
Net Income/Loss:
$-93.56M
P/E Ratio:
-2.3836
EPS:
-2.8361
Net Cash Flow:
$-85.76M
1W Performance:
+5.62%
1M Performance:
+37.68%
6M Performance:
+428.12%
1Y Performance:
+196.49%
1-Day Range:
$5.97
$6.78
1-Week Range:
$5.87
$6.78
52-Week Range:
$0.8801
$7.80
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
6.76 | 441.36M | 0 | -93.56M | -85.76M | -2.8361 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Initiated | Guggenheim | Buy |
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
PepGen's Phase 2 Trial of Drug to Treat Multisystem Disorder Placed on Hold by US FDA - marketscreener.com
US FDA puts partial clinical hold on PepGen's muscle disease drug trial - Reuters
FDA places partial clinical hold on PepGen’s DM1 trial - Investing.com India
Biotech firm PepGen's Q4 net loss narrows - TradingView
PepGen Faces FDA Partial Hold Amid Ongoing FREEDOM2 Trial - TipRanks
PepGen stock plunges 26% on FDA partial clinical hold - Investing.com
PepGen IncU.S. FDA places Freedom2 trial on partial clinical hold related to preclinical pharmacology and toxicology - marketscreener.com
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights - Yahoo Finance
PepGen Announces Regulatory Updates on FREEDOM2 - Business Wire
PEPG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PepGen to Participate in the Leerink Global Healthcare Conference - PharmiWeb.com
PepGen to join fireside chat at LeerinkPartners Global Healthcare Conference in Miami - Traders Union
Dividend Watch: Is ArrowMark Financial Corp currently under institutional pressure2025 Breakouts & Breakdowns & Proven Capital Preservation Tips - baoquankhu1.vn
Monashee Investment Management LLC Invests $1.39 Million in PepGen, Inc. $PEPG - MarketBeat
Oppenheimer Initiates Coverage of PepGen (PEPG) with Outperform Recommendation - Nasdaq
PepGen (NASDAQ:PEPG) Now Covered by Analysts at Oppenheimer - MarketBeat
Oppenheimer Initiates PepGen at Outperform With $15 Price Target - marketscreener.com
PepGen, Inc. (NASDAQ:PEPG) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Will PepGen Inc. stock go up in YEARWeekly Investment Summary & Smart Swing Trading Alerts - mfd.ru
Should I set a stop loss on PepGen Inc.Market Trend Review & Fast Gaining Stock Strategy Reports - mfd.ru
PepGen Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Guggenheim raises PepGen stock price target to $7 on trial outlook - Investing.com Nigeria
Guggenheim raises PepGen stock price target to $7 on trial outlook By Investing.com - Investing.com South Africa
PepGen (PEPG) Expected to Announce Earnings on Monday - MarketBeat
Does PepGen Inc. have a sustainable dividendForecast Cut & Precise Swing Trade Entry Alerts - mfd.ru
PEPG SEC FilingsPepGen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PepGen’s FREEDOM-DM1 Trial Reaches Early Safety Milestone for Myotonic Dystrophy - TipRanks
What technical signals suggest for PepGen Inc. stockProfit Target & Verified Entry Point Signals - mfd.ru
Can PepGen Inc. stock sustain institutional interestJuly 2025 Trends & Verified Swing Trading Watchlists - mfd.ru
Will PepGen Inc. benefit from rising consumer demandEarnings Beat & Detailed Earnings Play Alerts - mfd.ru
Why PepGen Inc. stock is in analyst buy zoneChart Signals & Precise Swing Trade Entry Alerts - mfd.ru
Can PepGen Inc. stock double in the next yearJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - mfd.ru
Risk On: Should I set a stop loss on PepGen IncJuly 2025 Setups & Weekly High Potential Alerts - baoquankhu1.vn
How much upside is left in PepGen (PEPG)? Wall Street analysts think 75.44% - MSN
Whale Trades: What are PepGen Incs growth leversJuly 2025 Volume & AI Driven Price Predictions - baoquankhu1.vn
PepGen, Inc. (NASDAQ:PEPG) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
PepGen reports Q3 EPS (52c), consensus (56c) - MSN
Levi & Korsinsky Notifies PepGen Inc. (PEPG) InvestorsLead Plaintiff Deadline on August 8, 2025 - The National Law Review
PepGen (NASDAQ:PEPG) Trading Down 2.6%What's Next? - MarketBeat
PepGen (NASDAQ:PEPG) Trading Down 2.6% – What’s Next? - Defense World
Risk Check: Will PepGen Inc benefit from rising consumer demandJuly 2025 Update & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Aug Retail: Does PepGen Inc have declining or rising EPSTrade Risk Summary & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Gains Report: Is electroCore Incs ROIC above industry averageWeekly Gains Summary & Real-Time Volume Surge Alerts - baoquankhu1.vn
Levels Update: Is Fox Corporation stock a buy or sellJuly 2025 Macro Moves & Long-Term Growth Plans - baoquankhu1.vn
PepGen outlines clinical trial phases for clarity - Traders Union
Risks Report: How liquid is PepGen Inc. stockWeekly Stock Recap & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Is PepGen Inc. a good stock for dollar cost averagingJuly 2025 Price Swings & Daily Price Action Insights - bollywoodhelpline.com
Does PepGen Inc have a sustainable dividendMarket Performance Report & Target Return Focused Stock Picks - baoquankhu1.vn
Earnings Miss: How rising interest rates impact XAI Octagon Floating Rate Alternative Income Trust stock2025 Support & Resistance & Momentum Based Trading Ideas - moha.gov.vn
AIM ImmunoTech, PepGen, Aeon, Tiziana, Moleculin: 5 Biotech Stocks That Led Retail Message Growth Last Week - MSN
Can PepGen Inc. stock deliver consistent earnings growth2025 Short Interest & Precise Swing Trade Entry Alerts - Улправда
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
6.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):